NASDAQ: CARA       Cara Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
12.50   +0.11 (0.89%)  11.94 - 12.87  276,474


Avg Volume (4 weeks):567,110
4 Weeks Range:8.88 - 16.41
4 Weeks Price Volatility (%):
52 Weeks Range:8.88 - 27.55
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Cara Therapeutics is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara’s objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3186  2660  283  2888 

Top 10 Active Counters
 LK 6.426-19.774 
 CCL 7.965-0.835 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 CHK 0.166+0.017 
 SQQQ 21.20-0.75 
 MRO 3.42+0.30 
 GE 6.85-0.19 
 F 4.315-0.085 
 OXY 12.71+1.97 
Partners & Brokers